International league against rheumatism: A brief history and update

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

American diabetes association and European league against rheumatism.

In the RECORD study (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycemia in Diabetes), rosiglitazone (Avandia, GlaxoSmithKline) plus standard therapy did not increase the risk of cardiovascular disease or death in the treatment of type-2 diabetes, but some safety concerns remain. Reporting RECORD results, Dr. Home, lead investigator, said: “We confirmed the overall cardiovas...

متن کامل

European League Against Rheumatism And American Diabetes Association.

We present EULAR sessions on the latest treatments for rheumatic disease with an infliximab biosimilar, certolizumab pegol, secukinumab, and bimekizumab. We also report on significant developments in diabetes presented at ADA's Scientific Sessions.

متن کامل

American Society of Clinical Oncology And European League Against Rheumatism.

Notable American Society of Clinical Oncology sessions focused on prostate cancer, non-small-cell lung cancer, and hepatocellular carcinoma. Subjects at the European Congress of Rheumatology included rheumatoid arthritis and axial spondyloarthritis.

متن کامل

Asbestos-related Lung Diseases: A Brief Update

Health risks from asbestos exposures have been evaluated, considering past professional histories when exposures at workplaces were higher than today. A linear no-threshold (LNT) model has been applied, although its relevance is unproven. Fibers are often found in the lungs and pleura of deceased people. Fiber findings do not prove that a disease is caused by asbestos. It is reasonable to assum...

متن کامل

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

BACKGROUND Since the publication of the European League Against Rheumatism recommendations for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence and new therapeutic agents have emerged. The objective was to update these recommendations. METHODS A systematic literature review was performed regarding pharmacological treatment in PsA. Subsequently, recommendations ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Arthritis & Rheumatism

سال: 1986

ISSN: 0004-3591,1529-0131

DOI: 10.1002/art.1780290719